immatics Appoints Peter Chambré as Chairman

News   Nov 12, 2012

 
immatics Appoints Peter Chambré as Chairman
 
 
 

RELATED ARTICLES

Immune Response Restored in Patients with Melanoma Thanks to New Compound

News

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.

READ MORE

Zika Vaccine Trials Provide Promising Results

News

Researchers report that an investigational Zika vaccine was well-tolerated and stimulated potentially protective immune responses in three Phase 1 clinical trials,

READ MORE

Blood Test Could Predict Skin Cancer's Return

News

Cancer Research UK scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE